{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:15:21Z","timestamp":1792793721354,"version":"4.5.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T00:00:00Z","timestamp":1614297600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T00:00:00Z","timestamp":1614297600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"The 900th Hospital of the Joint Logistic Support Force","award":["2018J07"],"award-info":[{"award-number":["2018J07"]}]},{"DOI":"10.13039\/501100013795","name":"Fujian Medical University","doi-asserted-by":"crossref","award":["2019QH1285"],"award-info":[{"award-number":["2019QH1285"]}],"id":[{"id":"10.13039\/501100013795","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s10238-021-00689-w","type":"journal-article","created":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T08:04:07Z","timestamp":1614326647000},"page":"369-377","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Clinicopathologic findings of chronic active Epstein\u2013Barr virus infection in adults: A single-center retrospective study in China"],"prefix":"10.1007","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6368-6455","authenticated-orcid":false,"given":"Jing","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haicong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaofang","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaolong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongliang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,26]]},"reference":[{"issue":"4","key":"689_CR1","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.it.2014.01.003","volume":"35","author":"AB Rickinson","year":"2014","unstructured":"Rickinson AB, Long HM, Palendira U, M\u00fcnz C, Hislop AD. Cellular immune controls over Epstein\u2013Barr virus infection: new lessons from the clinic and the laboratory. Trends Immunol. 2014;35(4):159\u201369. https:\/\/doi.org\/10.1016\/j.it.2014.01.003.","journal-title":"Trends Immunol"},{"issue":"2","key":"689_CR2","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1182\/blood.V98.2.280","volume":"98","author":"H Kimura","year":"2001","unstructured":"Kimura H, Hoshino Y, Kanegane H, Tsuge I, Okamura T, Kawa K, et al. Clinical and virologic characteristics of chronic active Epstein\u2013Barr virus infection. Blood. 2001;98(2):280\u20136.","journal-title":"Blood"},{"issue":"5","key":"689_CR3","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1007\/s12185-011-0831-x","volume":"93","author":"A Arai","year":"2011","unstructured":"Arai A, Imadome K-I, Watanabe Y, Yoshimori M, Koyama T, Kawaguchi T, et al. Clinical features of adult-onset chronic active Epstein\u2013Barr virus infection: a retrospective analysis. Int J Hematol. 2011;93(5):602\u20139. https:\/\/doi.org\/10.1007\/s12185-011-0831-x.","journal-title":"Int J Hematol"},{"issue":"6","key":"689_CR4","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.3324\/haematol.2017.174177","volume":"103","author":"K Kawamoto","year":"2018","unstructured":"Kawamoto K, Miyoshi H, Suzuki T, Kozai Y, Kato K, Miyahara M, et al. A distinct subtype of Epstein\u2013Barr virus-positive T\/NK-cell lymphoproliferative disorder: adult patients with chronic active Epstein\u2013Barr virus infection-like features. Haematologica. 2018;103(6):1018\u201328. https:\/\/doi.org\/10.3324\/haematol.2017.174177.","journal-title":"Haematologica"},{"issue":"5","key":"689_CR5","first-page":"2430","volume":"7","author":"R-C Wang","year":"2014","unstructured":"Wang R-C, Chang S-T, Hsieh Y-C, Huang W-T, Hsu J-D, Tseng C-E, et al. Spectrum of Epstein\u2013Barr virus-associated T-cell lymphoproliferative disorder in adolescents and young adults in Taiwan. Int J Clin Exp Pathol. 2014;7(5):2430\u20137.","journal-title":"Int J Clin Exp Pathol"},{"key":"689_CR6","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.3389\/fimmu.2017.01867","volume":"8","author":"H Kimura","year":"2017","unstructured":"Kimura H, Cohen JI. Chronic active Epstein\u2013Barr virus disease. Front Immunol. 2017;8:1867. https:\/\/doi.org\/10.3389\/fimmu.2017.01867.","journal-title":"Front Immunol"},{"issue":"1","key":"689_CR7","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12886-019-1090-5","volume":"19","author":"H Takahashi","year":"2019","unstructured":"Takahashi H, Takase H, Arai A, Mochizuki M, Ohno-Matsui K. Bilateral granulomatous panuveitis in two patients with T-cell type of chronic active Epstein\u2013Barr virus infection. BMC Ophthalmol. 2019;19(1):83. https:\/\/doi.org\/10.1186\/s12886-019-1090-5.","journal-title":"BMC Ophthalmol"},{"issue":"3","key":"689_CR8","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1182\/blood-2011-10-381921","volume":"119","author":"H Kimura","year":"2012","unstructured":"Kimura H, Ito Y, Kawabe S, Gotoh K, Takahashi Y, Kojima S, et al. EBV-associated T\/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases. Blood. 2012;119(3):673\u201386. https:\/\/doi.org\/10.1182\/blood-2011-10-381921.","journal-title":"Blood"},{"issue":"4","key":"689_CR9","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1177\/0961203317731532","volume":"27","author":"N Abdel-Wahab","year":"2018","unstructured":"Abdel-Wahab N, Talathi S, Lopez-Olivo MA, Suarez-Almazor ME. Risk of developing antiphospholipid antibodies following viral infection: a systematic review and meta-analysis. Lupus. 2018;27(4):572\u201383. https:\/\/doi.org\/10.1177\/0961203317731532.","journal-title":"Lupus"},{"issue":"3","key":"689_CR10","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s10238-020-00621-8","volume":"20","author":"J Qian","year":"2020","unstructured":"Qian J, Yu Q, Chen G, Wang M, Zhao Z, Zhang Y, et al. Altered ratio of circulating follicular regulatory T cells and follicular helper T cells during primary EBV infection. Clin Exp Med. 2020;20(3):373\u201380. https:\/\/doi.org\/10.1007\/s10238-020-00621-8.","journal-title":"Clin Exp Med"},{"issue":"3","key":"689_CR11","doi-asserted-by":"publisher","first-page":"189","DOI":"10.11406\/rinketsu.58.189","volume":"58","author":"E Onozawa","year":"2017","unstructured":"Onozawa E, Shibayama H, Imadome K-I, Tsuzura A, Koyama T, Miura O, et al. Inflammatory cytokine production in chronic active Epstein\u2013Barr virus infection. Rinsho Ketsueki. 2017;58(3):189\u201396. https:\/\/doi.org\/10.11406\/rinketsu.58.189.","journal-title":"Rinsho Ketsueki"},{"issue":"5","key":"689_CR12","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s12185-012-1170-2","volume":"96","author":"A Arai","year":"2012","unstructured":"Arai A, Nogami A, Imadome K-I, Kurata M, Murakami N, Fujiwara S, et al. Sequential monitoring of serum IL-6, TNF-\u03b1, and IFN-\u03b3 levels in a CAEBV patient treated by plasma exchange and immunochemotherapy. Int J Hematol. 2012;96(5):669\u201373. https:\/\/doi.org\/10.1007\/s12185-012-1170-2.","journal-title":"Int J Hematol"},{"issue":"4","key":"689_CR13","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1111\/bjh.14339","volume":"175","author":"AJJ Worth","year":"2016","unstructured":"Worth AJJ, Houldcroft CJ, Booth C. Severe Epstein\u2013Barr virus infection in primary immunodeficiency and the normal host. Br J Haematol. 2016;175(4):559\u201376. https:\/\/doi.org\/10.1111\/bjh.14339.","journal-title":"Br J Haematol"},{"issue":"5","key":"689_CR14","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.jhep.2006.02.006","volume":"44","author":"U Drebber","year":"2006","unstructured":"Drebber U, Kasper HU, Krupacz J, Haferkamp K, Kern MA, Steffen HM, et al. The role of Epstein\u2013Barr virus in acute and chronic hepatitis. J Hepatol. 2006;44(5):879\u201385.","journal-title":"J Hepatol"},{"issue":"2","key":"689_CR15","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1046\/j.1365-2893.2003.00486.x","volume":"11","author":"JY Lee","year":"2004","unstructured":"Lee JY, Chae DW, Kim SM, Nam ES, Jang MK, Lee JH, et al. Expression of FasL and perforin\/granzyme B mRNA in chronic hepatitis B virus infection. J Viral Hepat. 2004;11(2):130\u20135.","journal-title":"J Viral Hepat"},{"issue":"1","key":"689_CR16","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3760\/cma.j.issn.0529-5807.2019.01.016","volume":"48","author":"WP Liu","year":"2019","unstructured":"Liu WP. 2016 revision of WHO hematopoietic and lymphoid tissue tumor classification: T cell\/NK cell tumor. Zhonghua Bing Li Xue Za Zhi. 2019;48(1):58\u201362. https:\/\/doi.org\/10.3760\/cma.j.issn.0529-5807.2019.01.016.","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"issue":"2","key":"689_CR17","doi-asserted-by":"publisher","first-page":"137","DOI":"10.4132\/KoreanJPathol.2013.47.2.137","volume":"47","author":"M Hong","year":"2013","unstructured":"Hong M, Ko YH, Yoo KH, Koo HH, Kim SJ, Kim WS, et al. EBV-positive T\/NK-cell lymphoproliferative disease of childhood. Korean J Pathol. 2013;47(2):137\u201347. https:\/\/doi.org\/10.4132\/KoreanJPathol.2013.47.2.137.","journal-title":"Korean J Pathol"},{"issue":"4","key":"689_CR18","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/j.1440-1827.2008.02213.x","volume":"58","author":"K Ohshima","year":"2008","unstructured":"Ohshima K, Kimura H, Yoshino T, Kim CW, Ko YH, Lee S-S, et al. Proposed categorization of pathological states of EBV-associated T\/natural killer-cell lymphoproliferative disorder (LPD) in children and young adults: overlap with chronic active EBV infection and infantile fulminant EBV T-LPD. Pathol Int. 2008;58(4):209\u201317. https:\/\/doi.org\/10.1111\/j.1440-1827.2008.02213.x.","journal-title":"Pathol Int"},{"key":"689_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12113202","author":"S Fujiwara","year":"2020","unstructured":"Fujiwara S, Nakamura H. Chronic active Epstein\u2013Barr virus infection: is it immunodeficiency, malignancy, or both? Cancers (Basel). 2020. https:\/\/doi.org\/10.3390\/cancers12113202.","journal-title":"Cancers (Basel)"},{"key":"689_CR20","doi-asserted-by":"publisher","first-page":"502","DOI":"10.2741\/4322","volume":"20","author":"H Zhang","year":"2015","unstructured":"Zhang H, Yang W-T, Wang Z, Yao C-M, Wang X-F, Tian Z-Q, et al. Dehydroxymethylepoxyquinomicin selectively ablates T-CAEBV cells. Front Biosci (Landmark Ed). 2015;20:502\u201314.","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"57","key":"689_CR21","doi-asserted-by":"publisher","first-page":"31077","DOI":"10.18632\/oncotarget.25780","volume":"9","author":"E Onozawa","year":"2018","unstructured":"Onozawa E, Shibayama H, Takada H, Imadome K-I, Aoki S, Yoshimori M, et al. STAT3 is constitutively activated in chronic active Epstein\u2013Barr virus infection and can be a therapeutic target. Oncotarget. 2018;9(57):31077\u201389. https:\/\/doi.org\/10.18632\/oncotarget.25780.","journal-title":"Oncotarget"},{"key":"689_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19020451","author":"P Leone","year":"2018","unstructured":"Leone P, Vacca A, Dammacco F, Racanelli V. Common variable immunodeficiency and gastric malignancies. Int J Mol Sci. 2018. https:\/\/doi.org\/10.3390\/ijms19020451.","journal-title":"Int J Mol Sci."},{"issue":"1","key":"689_CR23","doi-asserted-by":"publisher","first-page":"e1486949","DOI":"10.1080\/2162402X.2018.1486949","volume":"8","author":"P Leone","year":"2019","unstructured":"Leone P, Di Lernia G, Solimando AG, Cicco S, Saltarella I, Lamanuzzi A, et al. Bone marrow endothelial cells sustain a tumor-specific CD8 T cell subset with suppressive function in myeloma patients. Oncoimmunology. 2019;8(1):e1486949. https:\/\/doi.org\/10.1080\/2162402X.2018.1486949.","journal-title":"Oncoimmunology"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-021-00689-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-021-00689-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-021-00689-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T14:15:25Z","timestamp":1625753725000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-021-00689-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,26]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["689"],"URL":"https:\/\/doi.org\/10.1007\/s10238-021-00689-w","relation":{},"ISSN":["1591-8890","1591-9528"],"issn-type":[{"value":"1591-8890","type":"print"},{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,26]]},"assertion":[{"value":"25 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All 19 patients provided written consent to use their data for research purposes, and specifically, for publication of this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}